Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sarepta’s External Controls Analysis Weakened By Elevidys Placebo Data Comparison
Aug 08 2023
•
By
Sue Sutter
FDA reviewers did not see a case for Elevidys' efficacy in Sarepta's external controls comparison. • Source: Shutterstock
More from Drug Review Profiles
More from Product Reviews